Member Info for LTbeliever

NFX is fully funded and money is being spent on specified/requested studies; we had waited 6 months for the FDA ODD, I am sure people can wait a few more weeks (only 7 weeks since the ODD). The Co will not / should not divulge any confidential details about its counterparties, both because of NDAs and because it will be to its own detriment. Patience is needed.

Should be hearing soon about the AGM and/or news with the AGM?

IMO Dan did well in getting the 1mln Vs lots of 200-300k raises every 3-4 months; firstly, it showed investors willing to fund it with 1 mln, secondly it allows NFX to focus on the p/ship deals, 3rdly as Soup right says, it gives NFX better leverage when the clock (of funds running out) is not ticking over Dan's head.

Last AFS (to eoSept 2025) indicated a cash burn of 600k, which included the extra costs of preparing for both the EMA and the FDA ODD applications; this year we have the costs for the specific studies requested by X (potential) partners, as per the RNS; money raised in early March 2026, therefore IMO should see the Co through to early 2027?

Dropping to 0.1 might make all of us (pess & optim) to average down, I guess? It'd mean a mkt cap of 2.2mln (almost half of it cash), and it'd be similar to Sept 2025 levels, prior to the FDA ODD (and funded in full for 2026). Possible? No idea.

No worries, PF, we are all "in" (both optimists and pessimists :)) ) ; waiting for the smart money to lead the way (next week maybe? :)) ).

I guess you are not "the smart money" then?

Soup, yes I agree; just saying that he could have opted for eg 200k but he chose to go for the BIG one instead, so as to focus on getting the deals done rather than worry in 3 months about another fundraise etc. We are on the same page, the problem was that he needed CMC for the raise and that "screwed" things up.

Just pre-empting!

And seeing that my post about optimists/pessimists has been "reported" and removed, let's have a guess at who got offended by it and reported it - a pessimist,perhaps?

With hindsight, had Dan not raised 1mln straight after the ODD designation the SP could have jumped to 0.40-0.60 on March 11th; OTOH, who can blame him for wanting to raise what he deemed was needed until p/ship deal/s are concluded? IMO, he had no choice, it was just bad luck that the CMC insiders used the opportunity to make a quick 30-50% on their investment.

Just IMO, Dan did so as he estimated there is a high probability of a deal within a ST horizon (already 1 1/2 month since ODD) thus, as each day goes by, the closer we are getting to the RNS. Let's wait a few more weeks and see (as pessimists will attack any optimism as PnD). GLA

1. the pessimists; "NPX002 is worthless", "same BS for the last 10 years", "part time job for Dan", "where are the partners", etc

2. the optimists; "it'll fly to 1p, 5p, 50p once news are released"

In my view, as we saw on March 11th, insiders were selling while the rest of us where absorbing the ODD news; my conclusion? The SP - if good news on a p/ship deal are imminent - will start moving upwards before any RNS is released for the rest of us. Co is funded for the next 12 months, so all we can do is wait for the - inevitable IMO - upwards movement in the SP; can the SP go down? Sure, because people do sell in the absence of news. DYOR

Better to have low volumes and calmness in the SP, whilst awaiting for the "p/ship" RNS, rather than wild swings in the SP that are driven by rumours; this allows proper Investors to buy into NFX, based on their own assessment of risk Vs reward, rather than getting tricked by PnD crews, IMO.

If/when this/these RNS/s come/s, then the SP will rise accordingly; in the meantime, holders can average down if willing to take a bit more risk. DYOR and be patient. GL to genuine holders.

Whether leaky or not, or P&D operation, today's action shows the dynamic behind the share and a small sample of the real action happening once the "deal" RNS lands at 7am one morning (soon, maybe?).

Looks like the MM is absorbing all amounts sold, possibly accumulating for SB (or themselves, in anticipation of news?)?

Missing trade of appx 149k shares; if indeed it's SB, then a TR1 should follow soon, as 1% increments are just 360k shares each time.

Bid was 2.50 y'day, 2.62 at open and now 2.66p so slow but steady uptrend; still waiting for the news!

It's quite likely that these "tests" started after October's Open Offer last October, for 2 reasons IMO (see link and extract, towards the end of section 2.):

a) Dan expected the ODD very soon, at the time b) the amount of funds raised implied a near-term ODD grant and a deal soon after.

https://www.lse.co.uk/rns/NFX/underwritten-open-offer-qsherpbdo3mlhuh.html

"It is anticipated that the outlined assessments can be completed via expert analysis of existing data. However, additional supporting data may need to be generated. Whilst the Group intends to use the net proceeds from the Open Offer to perform the outlined assessments, generate any additional supporting data, continue, and further develop, discussions with potential partners with the aim of securing an out-licence, option or collaborative agreement on the Company's NXP002 programme, it is possible that prospective licensees may require additional data over and above the studies already undertaken before an out-licensing transaction may be concluded"

If so, i.e. tests had started by eg Dec. 2025, this'd mean that a) there is a lot of interest b) we could have news in the very near future. Just IMO, pls DYOR.

Tnx for the info, Trombone; your figure is still 3-4x NFX's current mkt cap so it'd be still welcome.

BTW, pls correct me if wrong (FFXS, pls DO NOT read any further :) ) - NFX "appears" to be talking to multiple parties (big pharma and more specialist firms, as per RNSs), does this mean it could get upfront fees from more than 1 partner/s? Can collaborations be on a non-exclusive basis, therefore? Or, the only outcome would be - if more than 1 interested "partners" - a higher upfront fee due to this "competition'?

Tnx Soup; I guess this means less competition for NPX0002.

That TED can B/E on annual Sales of 1mln; it has a GM of appx 50%, fixed o/hs of 200-250k (maybe less once Adien/Utsi are out of the figures) and possibly another 200k for finance costs; a big unknown is how all the debts will be apportioned between the 3 entities; TED had the lowest portion of these on its books. With 1mln cash from UTSI (if approved) TED will be fully funded for at least another 12 months, when hopefully it will become profitable on its own. If Bayliss can merge/restructure TED with/into a bigger entity, this B/E point might go even lower IMO; but, the devil is in the details so we have to wait and see how things pan out.